recent studies have led to the development of a new ... · bilateral salpingectomy to the standard...
TRANSCRIPT
Type I tumors (low grade serous, low grade endometrioid, clear cell and mucinous carcinomas, and Brenner tumors) are generally indolent (but
chemoresistant!)and present in stage I (tumor confined to the ovary). They are characterized by specific mutations but rarely TP53 and are relatively stable
genetically.
Recent studies have led to the development of a new paradigm for the pathogenesis and origin of EOC, based on a dualistic model of carcinogenesis that divides EOC into 2 broad
categories designated types I and II.
Both type I and type II tumors develop from extraovarian tissue
that implants on the ovary. Both for LGSC and HGSC, the fallopian tube appears to be the source of the tumors
The mounting evidence that ovarian cancer does not develop in the ovary
and the lack of success of ovarian cancer screeningprovide a strong argument for directing efforts at prevention
Chan A, et al. Obstet Gynecol 2012
In women not at increased risk of ovarian cancer the disadvantages of prophylactic oophorectomy outweigh the
advantages up to the age of 65 years.
Reduction in the future risk of ovariancancer is the single most commonreason for normal ovaries to beremoved at the time of hysterectomy,particularly in the post-menopausalwomen
Over all, women with oophorectomy before 55 had about 8.5% excess mortality compared with ovarian conservation.
Women with oophorectomy before 59 had 4% excess mortality.
Parker WH, et al. Curr Opin Obstet Gynecol 2007
Parker WH, et al. Curr Opin Obstet Gynecol 2007
Harman H., et al. Climateric 2005
Nevertheless, the effects of salpingectomy on ovarian functions are still controversial. To the best of our knowledge, there are no strong
evidences on the effect of salpingectomy on surgical outcomes of a standard hysterectomy
It has been hypothesized that the destruction of the fallopian tube reduces the utero-ovarian arterial blood flow in the mesosalpinx, thereby leading to tissue damage to theovary. In addition, venous drainage may be compromised because venous plexuses arelocated near the arteries.
Cattanach JF, Milne BJ. Contraception 1988
However, given the dual ovarian blood supply, guaranteed both by infundibolopelvicvessels and from the ovarian branch of the uterine artery, and considering the additional anastomosis of these vessels at the tubal level, at the time of hysterectomy with salpingectomy, the whole infundibolopelvic blood volume, normally distributed between tubes and ovaries, becomes available to the ovaries.
Dietl J. Fertil Steril 2014
In order to validate a new preventive strategy, it is necessary to objectively asses
Assess the frequency of, and model the risk associated with STICs in both women at high risk and baseline risk for ovarian cancer and monitor gradual changes in the distribution of tumor histologies and patient history at diagnosis as a result of this initiative, and eventually determine if we have decreased
the number of ovarian cancers diagnosed per year.
in risk-reducing salpingectomy to ensure that these changes in surgical practice are both cost-
effective and safe to women
We retrospectively compared data of 79 patients who underwent TLH plus bilateral salpingectomy (group A),with
those of 79 women treated by standard TLH without adnexectomy (sTLH) (group B).
The goal of the study was to evaluate if ovarian function and surgical outcomes are modified by the addiction of
bilateral salpingectomy to the standard technique.
The data for these patients were compared with those of 79 women treated by standardTLH without adnexectomy, matched for uterine weight
A prior analysis conducted on our data demonstrated a post-operative AMH levels averagedecrease of 9% in women submitted to total laparoscopic hysterectomy with adnexalpreservation (standard procedure).
Assuming a 10% decrease with thisprocedure, and a maximal clinicallyacceptable decreasing for equivalence of15% in AMH levels in women aftersalpingectomy, a sample of at least 69patients per group would have given 95%power and a one-sided significance levelof 10%.
In our study, given a sample size of 79 patients in each group, power model resulted of 96.8%.
Nineteen patients (24%) submitted to TLH plus
salpingectomy in 2010, 22 (28%) in 2011 and 38 (48) in 2012
Venturella R. et al. Unpublished data!
Seventy-nine (100%) patients re-called to be submitted again to ovarian reserve evaluation in
2015
Eight (10.1%) women refused to participate to
the follow-up study
Seventy-one (89.9%) women accepted to participate and
were evaluated
Both women with and without menopausal symptoms have been analyzed. In ovulating women, ovarian reserve has been evaluated when early follicular phase has been confirmed by the presence of serum E2 level <60 pg/mL and P<1 ng/mL, in conjunction with ultrasound confirmation of the absence
of a dominant follicle >10mm in any of the ovaries.
The innovation introduced by our algorithm is that the final output is not a generic definition of good or poor ovarian reserve, like others tests already do.
Our test answers with a number, the patient’s OvAge.
Parameters Mean values±SD
Age at surgery (years) 45.85 ± 2.40
Age at follow-up (years) 49.61 ± 2.15
OvAge at follow-up (years) 49.34 ± 2.12
FSH at follow-up (mU/mL) 43.02 ± 19.92
AMH at follow-up (ng/mL) 0.12 ± 0.20
3D AFC at follow-up (n.) 1.91 ± 1.28
VI at follow-up (%) 2.80 ± 5.32
FI at follow-up (1-100) 19.37 ± 5.88
VFI at follow-up (1-100) 0.56 ± 1.12
Venturella R. et al. Unpublished data!
Recent evidence suggests that not only the fimbrial end of the tube but also the soft
tissues adjacent to the ovary in the mesosalpinx can give rise to neoplasms
According to this observation, simplesalpingectomy might not offer maximal
protection!
Objective: To study the effects of the radical excision of soft tissues adjacent to the ovary and fallopian tube on ovarian function and surgical outcomes in women undergoing laparoscopic bilateral prophylactic salpingectomy.
Design: Randomized-controlled trial (NCT02086370)
Setting: Magna Graecia University of Catanzaro
Patients: One-hundred-eighty-six women undergoing laparoscopic surgery for uterine myoma (n=143) or tubal surgical sterilization (n=43)between March 2014 and January 2015.
Main Outcome Measures: Ovarian reserve modification (Δ) prior to and post surgery was assessed as primary outcome. The operative time, variation of the haemoglobin level (ΔHb), postoperative hospital stay, postoperative return to normal activity, and complication rate were assessed as secondary outcomes.
Venturella R. et al. Under review on Fertil Steril 2015
Venturella R. et al. Under review on Fertil Steril 2015
Patients were randomly divided into two groups. In Group A (n=91), standard salpingectomywas performed. In Group B (n=95), the mesosalpinx was removed within the tubes.
Prior to and 3 months post surgery, AMH, FSH, 3D AFC, Vascular Index (VI), Flow Index (FI), Vascular-Flow Index (VFI) and OvAge were recorded for each patient.
Venturella R. et al. Under review on Fertil Steril 2015
Parameters Standard Salpingectomy
Group A (n.91)
Radical Salpingectomy
Group B (n.95)
p
Age (years) 41.16 ± 5.33 41.56 ± 5.45 0.61
Parity (children) 2.73 ± 1.1 2.60 ± 0.93 0.36
AMH (ng/mL) 0.93 ± 1.13 0.86 ± 1.01 0.65
FSH (mIU/mL) 12.97 ± 9.71 12.39 ± 7.88 0.66
E2 (pg/mL) 23.8±12.9 29.1±18.1 0.03
AFC (n) 7.80 ± 4.23 6.82 ± 4.68 0.14
VI (%) 0.97 ± 0.79 1.00 ± 0.98 0.43
FI (0-100) 31.28 ± 8.2 30.28 ± 9.07 0.79
VFI (0-100) 0.58 ± 0.48 0.55 ± 0.57 0.71
OvAge (years) 39.50 ± 5.43 40.13 ± 5.20 0.42
Baseline data
All data are expressed as mean and SD
Venturella R. et al. Under review on Fertil Steril 2015
Primary and secondary outcomes measures
Parameters Standard Salpingectomy
Group A (n.91)
Radical Salpingectomy
Group B (n.95)
p
Δ AMH (ng/mL) −0.09 ± 0.24 −0.07 ± 0.22 0.54
Δ FSH (mIU/ml) 0.47 ± 0.86 0.37 ± 0.84 0.40
Δ AFC (n) −0.33 ± 0.73 −0.26 ± 0.61 0.44
Δ VI (%) −0.10 ± 0.31 −0.11 ± 0.25 0.85
Δ FI (0-100) −0.74 ± 2.02 −0.61 ± 1.54 0.60
Δ VFI (0-100) −0.08 ± 0.23 −0.06 ± 0.21 0.61
Δ OvAge (years) 0.03 ± 0.12 0.04 ± 0.11 0.59
Operative time (min) 13.70 ± 5.70 15.01 ± 5.23 0.10
Δ Hb (g/dL) 1.52±0.79 1.35±0.83 0.17
Postoperative hospital stay (days) 2.07±0.70 2.14±0.66 0.48
Postoperative return to normal activity (days) 9.20±3.30 8.73±3.30 0.33
Complication rate (%) 0 0 -
All data are expressed as mean and SD
Venturella R. et al. Under review on Fertil Steril 2015
Even when the surgical excision includes the removal of the mesosalpinx, salpingectomy does
not damage the ovarian reserve. Moreover, radical salpingectomy with excision of the mesosalpinx did not alter blood loss, hospitalization stay, or return
to normal activities.
A demonstration of the absence of any detrimental effects of the radicalization of the currently practiced standard
technique for salpingectomy represents a new and important step in the long but exciting process that may
lead to one of the most important scientific revolutions in gynaecological surgery of the last few centuries.
The finding of equivalent outcomes in patients undergoing hysterectomy and salpingectomy, compared to hysterectomy alone, which was documented in the study by Morelli et al, is of general interest to the gynecology community, at this particular time,
because of recent changes in our understanding of the histogenesis of HGSC.
With regard to whether there are implications for subsequent ovarian function or an increased likelihood of complications, Morelli et al. have demonstrated that there are
no detectable complications of performing salpingectomy at the same time as hysterectomy, the data of which can be used immediately in counseling patients.
Venturella R. et al. Eur J Canc Prev 2015 In Press
The objective of the study was to examine obstetrician-gynaecologists’ knowledge, opinions, and practice patterns relating to opportunistic
salpingectomy in the general population.
An anonymous electronic survey was sent to all Obstetrics and Gynaecology Residency Program
Directors, Full and Associate Professors, Delegates of FIGO, SIGO and AOGOI.
The survey was available online for completion between January 3 and July 2, 2014
More than two thousand colleagues invited to participate
A total of 479 surveys were returned
The largest survey published on the topic !!!
Venturella R. et al. Eur J Canc Prev 2015 In Press
Residents3%
Hospital obstetricians and gynecologists
45%
Academic obstetricians and gynecologists
34%
Associate professors12%
Full professors6%
PRACTICE SETTING TYPOLOGY
Yes82%
No18%
Do you usually perform PBS in association with a hysterectomy without oophorectomy
for benign indications?
Venturella R. et al. Eur J Canc Prev 2015 In Press
To reduce the risk of pelvic
pain ; 38
To reduce the risk of cancer ; 371
To reduce the risk of reoperation ; 29
To reduce the risk of hydrosalpinges ; 66
IF YES, WHY DO YOU PERFORM PBS?
It increases the risk of surgical
complications ; 19 It increases operative time; 14
It does not decrease the
risk of ovarian and peritoneal
cancers; 9
The risk of reoperation is the same regardless of
whether bilateral salpingectomy is performed ; 24
There is no benefit; 47
IF NO, WHY NOT?
Venturella R. et al. Eur J Canc Prev 2015 In Press
No; 430
Yes; 47
Do you believe there are additional risks to performing PBS in addition to
hysterectomy or other form of tubal sterilization?
Yes, I was aware of the safety data
published about; 303
I have read the literature but I was not aware of the safety data published
about; 97
Yes, I have heard about
it at a conference ;
35
Yes, I was asked about by one or more patients ; 7
No, I had never heard of PBS; 21
It had happened before this survey to have information on the new and the possibility of
introducing PBS as a preventive measure?
Salpingectomy as a primary method of sterilization has notbeen considered routinely until the past few years.Interestingly, for individuals in whom sterilization fails, it hasbeen long been considered that bilateral salpingectomy isthe preferred method to ensure definitive treatment.
A recent case-control study over a 45-year period found that the risk of serous ovarian cancer after salpingectomy was reduced by more than 60% as compared with a group of
women who were either not sterilized or had a tubal interruption sterilization. Lessard-Anderson et al,. Gynecol Oncol 2013
The ideal BRCA carrier candidate for RRS would be: a premenopausal woman with a prior risk-reducing mastectomy desiring ovarian preservation for the medical and
cognitive benefits
The ideal trial to verify equivalence of salpingectomy (RRS) and salpingo-oophorectomy (PBSO) should include:• Salpingectomy once reproductive desire is accomplished (<40 ys)• CA125 and ETV every 6 months • Ovariectomy at 40 years with inspection for pathologic evidence of disease
If no evidence of ovarian cancer is found in the original cohort of RRS women equivalency trial of RSS to RRSO without the second surgery.
Anderson CK et al. Int J Gyn Cancer 2013
Salpingectomy can be considered at the completion of childbearing in women atincreased genetic risk of ovarian cancer who do not agree tosalpingooophorectomy. However, this is not a substitute for oophorectomy, whichshould still be performed as soon as the woman is willing to accept menopause,preferably by the age of 40 years. Women delaying or refusing risk-reducingoophorectomy will not receive the breast cancer risk reduction provided byoophorectomy.
RRSO between the ages of 35 and 40 years isrecommended for risk reduction in women at increasedgenetic risk of ovarian cancer. The age of RRSO may alsobe individualized according to the earliest age of onset inthe family and personal choices.
We are enrolling the first 80 patients who agree to implement PBS to LPS cholecystectomy (study group), starting from January 1, 2013. Other 80
patients who will ask us to undergo cholecystectomy without the addiction of PBS will constitute the control group
We are working with regional and national competent offices to develop a unique code for salpingectomy performed for OC risk
reduction.
To address specific genomic and transcriptomic risk pattern, different by BRCA mutation, in patients with HGSC
To validate already promising serum biomarkers and to try to address a
reliable cytological method to screen p53 positivity on tubal cells (both
obtained by cervicovaginal thin prep and by hysteroscopic collection)